- Investing Ideas
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
4
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
4 companies
argenx
Market Cap: €36.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€583.20
7D
-5.3%
1Y
4.3%
Elia Group
Market Cap: €13.9b
Develops and operates as a transmission system operator in Belgium and Germany.
ELI
€127.50
7D
-6.7%
1Y
55.5%
Groupe Bruxelles Lambert
Market Cap: €9.1b
Invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally.
GBLB
€75.45
7D
-4.8%
1Y
6.3%
UCB
Market Cap: €47.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€247.40
7D
-4.1%
1Y
41.2%